Coexpression cluster:C247: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0001017!1.05e-39!82;UBERON:0005743!1.66e-36!86;UBERON:0000073!4.89e-35!94;UBERON:0001016!4.89e-35!94;UBERON:0001049!2.15e-33!57;UBERON:0005068!2.15e-33!57;UBERON:0006241!2.15e-33!57;UBERON:0007135!2.15e-33!57;UBERON:0000955!9.18e-33!69;UBERON:0006238!9.18e-33!69;UBERON:0002616!3.01e-31!59;UBERON:0007023!3.50e-31!115;UBERON:0000924!3.44e-26!173;UBERON:0006601!3.44e-26!173;UBERON:0004121!1.56e-25!169;UBERON:0003080!5.41e-25!42;UBERON:0002780!7.48e-25!41;UBERON:0001890!7.48e-25!41;UBERON:0006240!7.48e-25!41;UBERON:0002346!6.65e-24!90;UBERON:0003075!2.02e-23!86;UBERON:0007284!2.02e-23!86;UBERON:0000153!4.73e-23!129;UBERON:0007811!4.73e-23!129;UBERON:0000033!5.54e-22!123;UBERON:0002020!6.82e-21!34;UBERON:0003528!6.82e-21!34;UBERON:0001893!7.98e-21!34;UBERON:0002791!3.92e-20!33;UBERON:0001869!1.04e-19!32;UBERON:0003056!1.61e-16!61;UBERON:0002619!1.50e-15!22;UBERON:0000956!1.75e-15!25;UBERON:0000203!1.75e-15!25;UBERON:0001950!2.25e-14!20;UBERON:0003076!1.94e-09!15;UBERON:0003057!1.94e-09!15;UBERON:0000475!4.27e-09!365;UBERON:0004732!3.81e-08!13;UBERON:0004733!1.27e-07!12;UBERON:0002028!1.27e-07!12;UBERON:0007277!1.27e-07!12;UBERON:0002308!7.07e-07!9;UBERON:0000125!7.07e-07!9;UBERON:0002420!9.78e-07!9;UBERON:0007245!9.78e-07!9;UBERON:0010009!9.78e-07!9;UBERON:0010011!9.78e-07!9;UBERON:0000454!9.78e-07!9 | |ontology_enrichment_uberon=UBERON:0001017!1.05e-39!82;UBERON:0005743!1.66e-36!86;UBERON:0000073!4.89e-35!94;UBERON:0001016!4.89e-35!94;UBERON:0001049!2.15e-33!57;UBERON:0005068!2.15e-33!57;UBERON:0006241!2.15e-33!57;UBERON:0007135!2.15e-33!57;UBERON:0000955!9.18e-33!69;UBERON:0006238!9.18e-33!69;UBERON:0002616!3.01e-31!59;UBERON:0007023!3.50e-31!115;UBERON:0000924!3.44e-26!173;UBERON:0006601!3.44e-26!173;UBERON:0004121!1.56e-25!169;UBERON:0003080!5.41e-25!42;UBERON:0002780!7.48e-25!41;UBERON:0001890!7.48e-25!41;UBERON:0006240!7.48e-25!41;UBERON:0002346!6.65e-24!90;UBERON:0003075!2.02e-23!86;UBERON:0007284!2.02e-23!86;UBERON:0000153!4.73e-23!129;UBERON:0007811!4.73e-23!129;UBERON:0000033!5.54e-22!123;UBERON:0002020!6.82e-21!34;UBERON:0003528!6.82e-21!34;UBERON:0001893!7.98e-21!34;UBERON:0002791!3.92e-20!33;UBERON:0001869!1.04e-19!32;UBERON:0003056!1.61e-16!61;UBERON:0002619!1.50e-15!22;UBERON:0000956!1.75e-15!25;UBERON:0000203!1.75e-15!25;UBERON:0001950!2.25e-14!20;UBERON:0003076!1.94e-09!15;UBERON:0003057!1.94e-09!15;UBERON:0000475!4.27e-09!365;UBERON:0004732!3.81e-08!13;UBERON:0004733!1.27e-07!12;UBERON:0002028!1.27e-07!12;UBERON:0007277!1.27e-07!12;UBERON:0002308!7.07e-07!9;UBERON:0000125!7.07e-07!9;UBERON:0002420!9.78e-07!9;UBERON:0007245!9.78e-07!9;UBERON:0010009!9.78e-07!9;UBERON:0010011!9.78e-07!9;UBERON:0000454!9.78e-07!9 | ||
|pathway_enrichment=1.68021345890663e-05;0.00265893779871974;5;272;Neuroactive ligand-receptor interaction (KEGG):04080!3.47189991265201e-05;0.00439542528941744;3;53;Amyotrophic lateral sclerosis (ALS) (KEGG):05014!0.0001061436277718;0.0111981527299249;5;401;Transmembrane transport of small molecules (Reactome):REACT_15518!1.1460283977764e-07;7.25435975792461e-05;6;197;Synaptic Transmission (Reactome):REACT_13685!1.24432917686229e-06;0.000262553456317944;3;18;Botulinum neurotoxicity (Reactome):REACT_11184!8.907224977488e-07;0.000262553456317944;4;62;{VAMP2,63} (Static Module):NA | |||
}} | }} |
Revision as of 14:59, 13 July 2012
Full id: C247_pons_locus_medulla_spinal_paracentral_medial_occipital
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
1.68021345890663e-05 | 0.00265893779871974 | 5 | 272 | Neuroactive ligand-receptor interaction (KEGG):04080 |
3.47189991265201e-05 | 0.00439542528941744 | 3 | 53 | Amyotrophic lateral sclerosis (ALS) (KEGG):05014 |
0.0001061436277718 | 0.0111981527299249 | 5 | 401 | Transmembrane transport of small molecules (Reactome):REACT_15518 |
1.1460283977764e-07 | 7.25435975792461e-05 | 6 | 197 | Synaptic Transmission (Reactome):REACT_13685 |
1.24432917686229e-06 | 0.000262553456317944 | 3 | 18 | Botulinum neurotoxicity (Reactome):REACT_11184 |
8.907224977488e-07 | 0.000262553456317944 | 4 | 62 | {VAMP2,63} (Static Module):NA |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0060053 | neurofilament cytoskeleton | 5.76452463698256e-09 |
GO:0005883 | neurofilament | 5.76452463698256e-09 |
GO:0044459 | plasma membrane part | 5.39356905720145e-07 |
GO:0030054 | cell junction | 5.39356905720145e-07 |
GO:0007268 | synaptic transmission | 6.66485268915385e-07 |
GO:0060052 | neurofilament cytoskeleton organization and biogenesis | 6.66485268915385e-07 |
GO:0051234 | establishment of localization | 1.10714024149718e-06 |
GO:0019226 | transmission of nerve impulse | 1.19931140373097e-06 |
GO:0051179 | localization | 2.90696985444759e-06 |
GO:0006810 | transport | 4.32552140686666e-06 |
GO:0007267 | cell-cell signaling | 4.32552140686666e-06 |
GO:0045104 | intermediate filament cytoskeleton organization and biogenesis | 1.20627154453211e-05 |
GO:0045103 | intermediate filament-based process | 1.39099149236477e-05 |
GO:0045110 | intermediate filament bundle assembly | 3.35002810673953e-05 |
GO:0005887 | integral to plasma membrane | 6.93337190746111e-05 |
GO:0005886 | plasma membrane | 6.93337190746111e-05 |
GO:0032501 | multicellular organismal process | 6.93337190746111e-05 |
GO:0031226 | intrinsic to plasma membrane | 6.93337190746111e-05 |
GO:0030424 | axon | 0.000123706784522979 |
GO:0045109 | intermediate filament organization | 0.0002341018288924 |
GO:0030135 | coated vesicle | 0.000267933225744423 |
GO:0016192 | vesicle-mediated transport | 0.000418809417604697 |
GO:0008088 | axon cargo transport | 0.000568172251123635 |
GO:0007275 | multicellular organismal development | 0.000568172251123635 |
GO:0005856 | cytoskeleton | 0.000698920488850127 |
GO:0007399 | nervous system development | 0.000902372266977661 |
GO:0008021 | synaptic vesicle | 0.000920014325211797 |
GO:0006836 | neurotransmitter transport | 0.00102372330387087 |
GO:0044425 | membrane part | 0.00102372330387087 |
GO:0043005 | neuron projection | 0.00108511220980445 |
GO:0005882 | intermediate filament | 0.00112117144533564 |
GO:0045111 | intermediate filament cytoskeleton | 0.00112117144533564 |
GO:0005200 | structural constituent of cytoskeleton | 0.0011391566271197 |
GO:0050804 | regulation of synaptic transmission | 0.00164217168261946 |
GO:0050877 | neurological system process | 0.00192181601951179 |
GO:0051969 | regulation of transmission of nerve impulse | 0.00192181601951179 |
GO:0048489 | synaptic vesicle transport | 0.00192181601951179 |
GO:0016044 | membrane organization and biogenesis | 0.00192883952669166 |
GO:0007270 | nerve-nerve synaptic transmission | 0.00203660384954451 |
GO:0022892 | substrate-specific transporter activity | 0.00205606845313884 |
GO:0015075 | ion transmembrane transporter activity | 0.00214531373740093 |
GO:0044430 | cytoskeletal part | 0.00214531373740093 |
GO:0030136 | clathrin-coated vesicle | 0.00214531373740093 |
GO:0042995 | cell projection | 0.00241759306773508 |
GO:0005230 | extracellular ligand-gated ion channel activity | 0.00301010924667021 |
GO:0031644 | regulation of neurological process | 0.00301895377699923 |
GO:0016023 | cytoplasmic membrane-bound vesicle | 0.00335209651229851 |
GO:0031988 | membrane-bound vesicle | 0.00346540054964109 |
GO:0007154 | cell communication | 0.00365036465590875 |
GO:0042165 | neurotransmitter binding | 0.00365036465590875 |
GO:0048856 | anatomical structure development | 0.00384311493099898 |
GO:0022891 | substrate-specific transmembrane transporter activity | 0.0040609291840681 |
GO:0003008 | system process | 0.00427800408195558 |
GO:0051649 | establishment of cellular localization | 0.00446159307994661 |
GO:0044456 | synapse part | 0.00450748968317031 |
GO:0022834 | ligand-gated channel activity | 0.0045637709753216 |
GO:0015276 | ligand-gated ion channel activity | 0.0045637709753216 |
GO:0016043 | cellular component organization and biogenesis | 0.0045637709753216 |
GO:0051641 | cellular localization | 0.00466686851699799 |
GO:0048731 | system development | 0.00486533136937667 |
GO:0032502 | developmental process | 0.00514003969057503 |
GO:0022857 | transmembrane transporter activity | 0.00526040200093909 |
GO:0031410 | cytoplasmic vesicle | 0.00531710148004648 |
GO:0005234 | extracellular-glutamate-gated ion channel activity | 0.00531710148004648 |
GO:0031982 | vesicle | 0.00553543088521537 |
GO:0045761 | regulation of adenylate cyclase activity | 0.00569918910307809 |
GO:0051339 | regulation of lyase activity | 0.00580484496877022 |
GO:0031279 | regulation of cyclase activity | 0.00580484496877022 |
GO:0005515 | protein binding | 0.00627792290736801 |
GO:0010324 | membrane invagination | 0.00627792290736801 |
GO:0006897 | endocytosis | 0.00627792290736801 |
GO:0060181 | female receptivity | 0.00655659780821679 |
GO:0045924 | regulation of female receptivity | 0.00655659780821679 |
GO:0033596 | TSC1-TSC2 complex | 0.00655659780821679 |
GO:0060180 | female mating behavior | 0.00655659780821679 |
GO:0050795 | regulation of behavior | 0.00655659780821679 |
GO:0032222 | regulation of synaptic transmission, cholinergic | 0.00655659780821679 |
GO:0032223 | negative regulation of synaptic transmission, cholinergic | 0.00655659780821679 |
GO:0008090 | retrograde axon cargo transport | 0.00655659780821679 |
GO:0001589 | dopamine D5 receptor activity | 0.00655659780821679 |
GO:0033693 | neurofilament bundle assembly | 0.00655659780821679 |
GO:0022836 | gated channel activity | 0.00783831692333591 |
GO:0046907 | intracellular transport | 0.00911087086016492 |
GO:0001507 | acetylcholine catabolic process in synaptic cleft | 0.0110593733437102 |
GO:0043237 | laminin-1 binding | 0.0110593733437102 |
GO:0003990 | acetylcholinesterase activity | 0.0110593733437102 |
GO:0033057 | reproductive behavior in a multicellular organism | 0.0110593733437102 |
GO:0019896 | axon transport of mitochondrion | 0.0110593733437102 |
GO:0031133 | regulation of axon diameter | 0.0110593733437102 |
GO:0050805 | negative regulation of synaptic transmission | 0.0110593733437102 |
GO:0006581 | acetylcholine catabolic process | 0.0110593733437102 |
GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | 0.0110593733437102 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 0.0110593733437102 |
GO:0030815 | negative regulation of cAMP metabolic process | 0.0110593733437102 |
GO:0051966 | regulation of synaptic transmission, glutamatergic | 0.0110593733437102 |
GO:0001588 | dopamine D1 receptor-like receptor activity | 0.0110593733437102 |
GO:0019932 | second-messenger-mediated signaling | 0.0111195460700301 |
GO:0005231 | excitatory extracellular ligand-gated ion channel activity | 0.0117553069406724 |
GO:0001505 | regulation of neurotransmitter levels | 0.0136251482154584 |
GO:0032940 | secretion by cell | 0.0142129165712312 |
GO:0016020 | membrane | 0.0142129165712312 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.0142129165712312 |
GO:0043236 | laminin binding | 0.0142129165712312 |
GO:0008291 | acetylcholine metabolic process | 0.0142129165712312 |
GO:0030800 | negative regulation of cyclic nucleotide metabolic process | 0.0142129165712312 |
GO:0030346 | protein phosphatase 2B binding | 0.0142129165712312 |
GO:0030809 | negative regulation of nucleotide biosynthetic process | 0.0142129165712312 |
GO:0001992 | regulation of systemic arterial blood pressure by vasopressin | 0.0142129165712312 |
GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process | 0.0142129165712312 |
GO:0051970 | negative regulation of transmission of nerve impulse | 0.0142129165712312 |
GO:0042220 | response to cocaine | 0.0142129165712312 |
GO:0014073 | response to tropane | 0.0142129165712312 |
GO:0019933 | cAMP-mediated signaling | 0.0147949686011322 |
GO:0005216 | ion channel activity | 0.0167255681365211 |
GO:0008066 | glutamate receptor activity | 0.0168727651275069 |
GO:0007010 | cytoskeleton organization and biogenesis | 0.0168727651275069 |
GO:0022838 | substrate specific channel activity | 0.0169913913045988 |
GO:0022803 | passive transmembrane transporter activity | 0.0171090747376351 |
GO:0015267 | channel activity | 0.0171090747376351 |
GO:0004104 | cholinesterase activity | 0.0171090747376351 |
GO:0035249 | synaptic transmission, glutamatergic | 0.0171090747376351 |
GO:0007191 | dopamine receptor, adenylate cyclase activating pathway | 0.0171090747376351 |
GO:0002076 | osteoblast development | 0.0171090747376351 |
GO:0050840 | extracellular matrix binding | 0.0171090747376351 |
GO:0043228 | non-membrane-bound organelle | 0.0177843020348907 |
GO:0043232 | intracellular non-membrane-bound organelle | 0.0177843020348907 |
GO:0008306 | associative learning | 0.0199303464299923 |
GO:0008035 | high-density lipoprotein binding | 0.0199303464299923 |
GO:0030817 | regulation of cAMP biosynthetic process | 0.0199303464299923 |
GO:0008089 | anterograde axon cargo transport | 0.0199303464299923 |
GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 0.0199303464299923 |
GO:0004439 | phosphoinositide 5-phosphatase activity | 0.0199303464299923 |
GO:0042439 | ethanolamine and derivative metabolic process | 0.0199303464299923 |
GO:0046903 | secretion | 0.0220853584299826 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 0.0220853584299826 |
GO:0031594 | neuromuscular junction | 0.0222341222275618 |
GO:0019098 | reproductive behavior | 0.0222341222275618 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 0.0222341222275618 |
GO:0030808 | regulation of nucleotide biosynthetic process | 0.0222341222275618 |
GO:0007617 | mating behavior | 0.0222341222275618 |
GO:0045980 | negative regulation of nucleotide metabolic process | 0.0222341222275618 |
GO:0048488 | synaptic vesicle endocytosis | 0.0222341222275618 |
GO:0030814 | regulation of cAMP metabolic process | 0.0222341222275618 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 0.0224568120805291 |
GO:0022607 | cellular component assembly | 0.0245546746794124 |
GO:0031645 | negative regulation of neurological process | 0.0245546746794124 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 0.0245546746794124 |
GO:0005332 | gamma-aminobutyric acid:sodium symporter activity | 0.0245546746794124 |
GO:0001963 | synaptic transmission, dopaminergic | 0.0245546746794124 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 0.0245546746794124 |
GO:0008503 | benzodiazepine receptor activity | 0.0245546746794124 |
GO:0009611 | response to wounding | 0.0254724008806108 |
GO:0006869 | lipid transport | 0.0257109825227417 |
GO:0004445 | inositol-polyphosphate 5-phosphatase activity | 0.0259850654483273 |
GO:0045776 | negative regulation of blood pressure | 0.0259850654483273 |
GO:0042135 | neurotransmitter catabolic process | 0.0259850654483273 |
GO:0050886 | endocrine process | 0.0259850654483273 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 0.0259850654483273 |
GO:0015185 | L-gamma-aminobutyric acid transmembrane transporter activity | 0.0259850654483273 |
GO:0016079 | synaptic vesicle exocytosis | 0.0259850654483273 |
GO:0043279 | response to alkaloid | 0.0259850654483273 |
GO:0015277 | kainate selective glutamate receptor activity | 0.0259850654483273 |
GO:0046030 | inositol trisphosphate phosphatase activity | 0.0259850654483273 |
GO:0030594 | neurotransmitter receptor activity | 0.0260856382739532 |
GO:0045211 | postsynaptic membrane | 0.0286922244060811 |
GO:0031526 | brush border membrane | 0.0286922244060811 |
GO:0001540 | beta-amyloid binding | 0.0313005149388685 |
GO:0006140 | regulation of nucleotide metabolic process | 0.0313005149388685 |
GO:0045777 | positive regulation of blood pressure | 0.0313005149388685 |
GO:0045184 | establishment of protein localization | 0.0324215379354728 |
GO:0042402 | biogenic amine catabolic process | 0.033619649627795 |
GO:0014070 | response to organic cyclic substance | 0.033619649627795 |
GO:0031253 | cell projection membrane | 0.033619649627795 |
GO:0046873 | metal ion transmembrane transporter activity | 0.0348795867831052 |
GO:0042577 | lipid phosphatase activity | 0.0348795867831052 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 0.0348795867831052 |
GO:0051705 | behavioral interaction between organisms | 0.0348795867831052 |
GO:0007271 | synaptic transmission, cholinergic | 0.0348795867831052 |
GO:0042734 | presynaptic membrane | 0.0348795867831052 |
GO:0005283 | sodium:amino acid symporter activity | 0.0348795867831052 |
GO:0007618 | mating | 0.0348795867831052 |
GO:0008104 | protein localization | 0.0348795867831052 |
GO:0007018 | microtubule-based movement | 0.0367252912294252 |
GO:0005416 | cation:amino acid symporter activity | 0.0367252912294252 |
GO:0030866 | cortical actin cytoskeleton organization and biogenesis | 0.0367252912294252 |
GO:0004999 | vasoactive intestinal polypeptide receptor activity | 0.0367252912294252 |
GO:0017156 | calcium ion-dependent exocytosis | 0.0367252912294252 |
GO:0006886 | intracellular protein transport | 0.0378025738124215 |
GO:0030865 | cortical cytoskeleton organization and biogenesis | 0.0383055765245929 |
GO:0042982 | amyloid precursor protein metabolic process | 0.0383055765245929 |
GO:0030552 | cAMP binding | 0.0383055765245929 |
GO:0042219 | amino acid derivative catabolic process | 0.0383055765245929 |
GO:0044464 | cell part | 0.0383055765245929 |
GO:0033036 | macromolecule localization | 0.0389750845834086 |
GO:0007194 | negative regulation of adenylate cyclase activity | 0.0401888459378791 |
GO:0051350 | negative regulation of lyase activity | 0.0401888459378791 |
GO:0031280 | negative regulation of cyclase activity | 0.0401888459378791 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 0.0405545026518932 |
GO:0003073 | regulation of systemic arterial blood pressure | 0.0419964870842404 |
GO:0042310 | vasoconstriction | 0.0419964870842404 |
GO:0050714 | positive regulation of protein secretion | 0.0419964870842404 |
GO:0016021 | integral to membrane | 0.0432250967315281 |
GO:0030137 | COPI-coated vesicle | 0.0433088025382806 |
GO:0050435 | beta-amyloid metabolic process | 0.0433088025382806 |
GO:0007212 | dopamine receptor signaling pathway | 0.0433088025382806 |
GO:0019903 | protein phosphatase binding | 0.0433088025382806 |
GO:0007612 | learning | 0.0433088025382806 |
GO:0008289 | lipid binding | 0.0434730328223996 |
GO:0031224 | intrinsic to membrane | 0.0438426697017679 |
GO:0001518 | voltage-gated sodium channel complex | 0.0451813700461926 |
GO:0004012 | phospholipid-translocating ATPase activity | 0.0463462548699017 |
GO:0006171 | cAMP biosynthetic process | 0.0463462548699017 |
GO:0015247 | aminophospholipid transporter activity | 0.0463462548699017 |
GO:0035240 | dopamine binding | 0.0463462548699017 |
GO:0004952 | dopamine receptor activity | 0.0463462548699017 |
GO:0005518 | collagen binding | 0.0463462548699017 |
GO:0007601 | visual perception | 0.0469904287170701 |
GO:0050953 | sensory perception of light stimulus | 0.0469904287170701 |
GO:0006892 | post-Golgi vesicle-mediated transport | 0.0497964531035081 |
GO:0007215 | glutamate signaling pathway | 0.0497964531035081 |
GO:0051047 | positive regulation of secretion | 0.0497964531035081 |
GO:0016208 | AMP binding | 0.0497964531035081 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.